We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

immatics Appoints Dr. Harald Stock to its Board

Dr. Stock was Chairman and Managing Director of the German DePuy Group, the orthopeadics division of Johnson & Johnson, from 2006 to the end of 2008.
News

NIH Study Identifies Gene that Suppresses Cell's Immune Activation

FOXO3 gene suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
News

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

Merger to facilitate the initiation of the NeuVax™ phase III trial in HER2 positive patients not eligible for Herceptin® in 1H 2012.
News

NIH Study Identifies Gene that Suppresses Cell’s Immune Activation

A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
News

Immunovaccine Receives $2.9M from ACOA

Company to develop new diagnostics to identify specific subsets of cancer patient populations that would benefit most from receiving DepoVax™-based vaccine therapies.
News

Cleveland BioLabs Announces Potential Direct Anticancer Effect of CBLB502

CBLB502 has direct anticancer effect in several transplanted cancer models grown in mice and rats including colon and lung cancer, lymphoma and melanoma.
News

Stellar Biotechnologies Achieves Major Milestone

Company announces completion of preclinical toxicity and immunogenicity testing of Stellar KLH/IMG and Stellar Subunit KLH in rodent and non-rodent species.
News

NewLink Genetics to Present Phase 2 Data of its HyperAcute® Pancreas Immunotherapy

The data will be presented during a poster session at the ASCO 2011 Gastrointestinal Cancers Symposium in San Francisco, California.
News

Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology

The data from the collaboration explores the use of RXi's RNAi technology to develop proprietary vaccine formulations for active immunotherapy.
News

Immutep and GlaxoSmithKline Sign Licence Agreement for IMP731 for the Treatment of Autoimmune Diseases

The licence agreement grants GSK exclusive rights to depleting LAG-3 antibodies including ImmuTune IMP731.
Advertisement